Physician
Oncology
Dr. Linnea I. Chap, MD
|
|
Give Review
Linnea Chap works in the field of Oncology. She researched medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine She received 7 awards: "America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California", "CMS Meaningful Use Stage 1 Certification", "Redbook Magazine: Top Breast Cancer Doctors" and "Super Doctor". Linnea I. Chap, MD is a published doctor as well. She has 18 publications published. The latest was: Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. She accepts all Medicare patients.
Publications
- A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors.
- Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
- Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer.
- The Revlon/UCLA Breast Center Practice Guidelines for the Treatment of Breast Disease.
- Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma.
- Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia.
- Case report 827: Miliary osteosarcomatosis.
- Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X.
- The clinical application of recombinant erythropoietin in the HIV-infected patient.
- Extreme hyperkalemia induced by drugs.
- Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood prog...
- Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
- Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
- Miliary osteosarcomatosis with associated hypocalcemia.
- Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.
- Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
- Adjuvant docetaxel for node-positive breast cancer.
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- CMS Meaningful Use Stage 1 Certification
- Redbook Magazine: Top Breast Cancer Doctors
- Super Doctor
Education
-
UCLA Medical Center -
McGaw Medical Center of Northwestern University -
University of Chicago Pritzker School of Medicine
Hospital
-
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1700839362 | |
| NPPES Provider LastName | CHAP | |
| NPPES Provider FirstName | LINNEA | |
| NPPES Provider ZIPCode | 902111958 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 688.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 2.47 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700839362 |
| Last Name Of The Provider | CHAP |
| First Name Of The Provider | LINNEA |
| View All |
Similar Doctors
|
Dr. David M. Hoffman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Fred P. Rosenfelt, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Charles L. Wiseman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noam Z. Drazin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David B. Agus, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Patrick Soon-Shiong, MD |